Cargando…
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
PURPOSE: About 20–25% of patients experience weight regain (WR) or insufficient weight loss (IWL) after bariatric metabolic surgery (BS). Therefore, we aimed to retrospectively assess the effectiveness of adjunct treatment with the GLP-1 receptor agonist semaglutide in non-diabetic patients with WR...
Autores principales: | Lautenbach, Anne, Wernecke, Marie, Huber, Tobias B., Stoll, Fabian, Wagner, Jonas, Meyhöfer, Sebastian M., Meyhöfer, Svenja, Aberle, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532334/ https://www.ncbi.nlm.nih.gov/pubmed/35879524 http://dx.doi.org/10.1007/s11695-022-06211-9 |
Ejemplares similares
-
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery
por: Lautenbach, Anne, et al.
Publicado: (2022) -
Patients’ Experiences of Weight Regain After Bariatric Surgery
por: Tolvanen, Liisa, et al.
Publicado: (2022) -
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
por: Jensen, Anders Boisen, et al.
Publicado: (2023) -
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgery
por: Poublon, Nathan, et al.
Publicado: (2020) -
Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery
por: Lautenbach, Anne, et al.
Publicado: (2021)